GAFFX | VSPGX | GAFFX / VSPGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 6 years | - |
Gain YTD | 34.331 | 40.314 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 313B | 14.4B | 2,174% |
Annual Yield % from dividends | 0.75 | 0.89 | 84% |
Returns for 1 year | 35.71 | 40.28 | 89% |
Returns for 3 years | 19.35 | 29.74 | 65% |
Returns for 5 years | 57.06 | 119.94 | 48% |
Returns for 10 years | N/A | 307.38 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.50 | 0.24 | +0.87% |
First Trust Nasdaq Pharmaceuticals ETF | |||
FXE | 96.84 | -0.16 | -0.16% |
Invesco CurrencyShares® Euro Currency | |||
QQMG | 36.36 | -0.16 | -0.44% |
Invesco ESG NASDAQ 100 ETF | |||
PRF | 41.38 | -0.27 | -0.65% |
Invesco FTSE RAFI US 1000 ETF | |||
CDC | 63.17 | -0.43 | -0.68% |
VictoryShares US EQ Inc Enh Vol Wtd ETF |